Confirming your payment

Skip to content

Practice Questions · Question 1 of 30

A company has engineered an E.

Question 11 markMCQMedium

A company has engineered an E. coli strain that makes a human protein at a high rate in small laboratory flasks. When production is moved to a large bioreactor, two problems appear:

Problem 1: the temperature and oxygen supply vary from one part of the vessel to another, and the yield per litre falls.

Problem 2: the protein recovered at the end is mixed with other materials from the cells and the medium.

Which of the three critical research areas of biotechnology need further work?

Select your answer
  • (A) Providing the best catalyst and creating optimal conditions; downstream processing is already adequate.

  • (B) Creating optimal conditions and downstream processing; the catalyst itself does not need to be changed.

    Correct answer
  • (C) Providing the best catalyst and downstream processing; the conditions in the bioreactor are already adequate.

  • (D) Providing the best catalyst only, because a better strain would solve both of these problems on its own.